Identification of a novel off-target of paroxetine: possible role in sexual dysfunction induced by this SSRI antidepressant drug.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Molecular Structure

• Publication date

  2022-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.molstruc.2022.133690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Catecholamines in Pathophysiological Liver Processes

  2022cited by this paper
• MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines

  2022cited by this paper
• Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target

  2021cited by this paper
• Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect

  2021cited by this paper
• Paroxetine—Overview of the Molecular Mechanisms of Action

  2021cited by this paper
• Comparative efficacy and safety of drug treatment for premature ejaculation: A systemic review and Bayesian network meta‐analysis

  2020cited by this paper
• Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital

  2020cited by this paper
• Identification and in vivo validation of a 9-mer peptide derived from FSHβ with FSHR antagonist activity.

  2020cited by this paper
• Adrenergic receptors and cardiovascular effects of catecholamines.

  2020cited by this paper
• Monoaminergic system and depression

  2019cited by this paper
• Antidepressants act by binding to the cholesterol-interaction site at TRKB neurotrophin receptor

  2019cited by this paper
• 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.

  2019cited by this paper
• Tuning PFKFB3 Bisphosphatase Activity Through Allosteric Interference

  2019cited by this paper
• Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.

  2019cited by this paper
• Male sexual dysfunction: A review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention.

  2019cited by this paper
• A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.

  2018cited by this paper
• An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings

  2018cited by this paper
• Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

  2018cited by this paper
• Assessing finasteride‐associated sexual dysfunction using the FAERS database

  2017cited by this paper
• Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats

  2016cited by this paper
• Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required.

  2016cited by this paper
• Improved Computation of Protein-Protein Relative Binding Energies with the Nwat-MMGBSA Method

  2016cited by this paper
• Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015.

  2016cited by this paper
• Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: A role for 5-HT1A receptors?

  2016cited by this paper
• A brief history of the development of antidepressant drugs: from monoamines to glutamate.

  2015cited by this paper
• Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low‐Dose Finasteride: A Pharmacovigilance Study

  2015cited by this paper
• Peripheral and central effects of circulating catecholamines.

  2014cited by this paper
• Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects

  2014cited by this paper
• SPILLO‐PBSS: Detecting hidden binding sites within protein 3D‐structures through a flexible structure‐based approach

  2014cited by this paper
• Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?

  2014cited by this paper
• Explicit Ligand Hydration Shells Improve the Correlation between MM-PB/GBSA Binding Energies and Experimental Activities.

  2013cited by this paper
• Variability in docking success rates due to dataset preparation

  2012cited by this paper
• A Review of its Pharmacology and Therapeutic Potential in the Management of Panic Disorder

  2012cited by this paper
• Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion

  2011cited by this paper
• Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction

  2011cited by this paper
• Adverse effect of paroxetine on sperm.

  2010cited by this paper
• Determination of 5-Hydroxytryptamine, Norepinephrine, Dopamine and Their Metabolites in Rat Brain Tissue by LC–ESI–MS–MS

  2009cited by this paper
• Molecular recognition of physiological substrate noradrenaline by the adrenaline-synthesizing enzyme PNMT and factors influencing its methyltransferase activity.

  2009cited by this paper
• Rho kinase is involved in Ca2+ entry of rat penile small arteries.

  2008cited by this paper
• Physiological regulation of penile arteries and veins

  2008cited by this paper
• Contribution of both Ca2+ entry and Ca2+ sensitization to the alpha1-adrenergic vasoconstriction of rat penile small arteries.

  2007cited by this paper
• α1‐Adrenoceptor subtypes in isolated corporal tissue from patients undergoing gender re‐assignment

  2006cited by this paper
• Dopamine beta-hydroxylase deficiency

  2006cited by this paper
• Paroxetine: a review.

  2006cited by this paper
• Penile Arteries and Erection

  2002cited by this paper
• Prevalence of sexual dysfunction among newer antidepressants.

  2002cited by this paper
• The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment

  2002cited by this paper
• Catecholaminergic projections onto spinal neurons destined to the pelvis including the penis in rat

  2002cited by this paper
• Differential effects of serotonin reuptake inhibitors on erectile responses, NO‐production, and neuronal NO synthase expression in rat corpus cavernosum tissue

  2001cited by this paper
• Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

  2001cited by this paper
• Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

  2000cited by this paper
• Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection.

  2000cited by this paper
• Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.

  1998cited by this paper
• Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study

  1998cited by this paper
• SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

  1997cited by this paper
• VMD: visual molecular dynamics.

  1996cited by this paper
• Physiology of penile erection.

  1995cited by this paper
• A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char

  1993cited by this paper

• In silico analysis of the multitarget potential of GlyT1 inhibitors in SLC6 transporters.

  2026cites this paper
• Photocatalytic Degradation Study of Paroxetine with g-C3N4 Prepared Using Different Precursors in Lab- and Pilot-Scale Conditions

  2025cites this paper
• The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations

  2025influential citation
• Chikusetsusaponin IVa ameliorates paroxetine-induced Leydig cells (TM3 cells) injury via the Nrf2/HO-1 signaling pathway.

  2025cites this paper
• Optimized QuEChERS Methodology for Reliable LC-MS/MS Quantification of Sertraline and Fluoxetine Hydrochloride in Biological Samples

  2024cites this paper
• Target identification by structure-based computational approaches: recent advances and perspectives.

  2023cites this paper
• POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE.

  2023cites this paper
• Extract of Pfaffia glomerata Ameliorates Paroxetine-Induced Sexual Dysfunction in Male Mice and the Characterization of Its Phytoconstituents by UPLC-MS

  2023cites this paper
• Binding studies of sertraline hydrochloride with CT-DNA using experimental and computational techniques.

  2023cites this paper